$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

$bdrl Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000114420415065561 Filed on November 16, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$5.210M	$5.704M	$8.659M
YoY Change	-14.03%	-34.13%	26.91%
Cost Of Revenue	$4.750M	$4.931M	$5.173M
YoY Change	24.35%	-4.68%	13.69%
Gross Profit	$470.0K	$773.0K	$3.486M
YoY Change	-79.02%	-77.83%	53.37%
Gross Profit Margin	9.02%	13.55%	40.26%
Selling, General & Admin	$1.750M	$1.779M	$1.968M
YoY Change	-14.22%	-9.6%	-7.04%
% of Gross Profit	372.34%	230.14%	56.45%
Research & Development	$730.0K	$869.0K	$865.0K
YoY Change	-6.41%	0.46%	10.9%
% of Gross Profit	155.32%	112.42%	24.81%
Depreciation & Amortization	$310.0K	$360.0K	$360.0K
YoY Change	-8.82%	0.0%	16.13%
% of Gross Profit	65.96%	46.57%	10.33%
Operating Expenses	$2.480M	$2.648M	$2.833M
YoY Change	-12.37%	-6.53%	-2.21%
Operating Profit	-$2.010M	-$1.875M	$653.0K
YoY Change	240.68%	-387.14%	-204.65%
Interest Expense	-$80.00K	$83.00K	$69.00K
YoY Change	33.33%	20.29%	7.81%
% of Operating Profit			10.57%
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.090M	-$1.958M	$584.0K
YoY Change	226.56%	-435.27%	-184.88%
Income Tax	$50.00K	$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$2.140M	-$1.958M	$584.0K
YoY Change	219.4%	-435.27%	-184.88%
Net Earnings / Revenue	-41.07%	-34.33%	6.74%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.32	-$0.30	$0.09
COMMON SHARES
Basic Shares Outstanding	6.555M shares	6.555M shares	6.226M shares
Diluted Shares Outstanding		6.555M shares	6.320M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.00K	$300.0K	$1.430M
YoY Change	-95.65%	-79.02%	2760.0%
Cash & Equivalents	$9.000K	$304.0K	$1.430M
Short-Term Investments
Other Short-Term Assets	$280.0K	$280.0K	$1.120M
YoY Change	-56.92%	-75.0%	23.08%
Inventory	$5.595M	$7.620M	$8.014M
Prepaid Expenses
Receivables	$2.432M	$2.170M	$2.681M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.313M	$10.38M	$13.24M
YoY Change	-33.84%	-21.61%	0.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.621M	$3.740M	$3.879M
YoY Change	-7.7%	-3.58%	3.0%
Goodwill	$493.0K		$493.0K
YoY Change	0.0%		0.0%
Intangibles	$458.0K		$617.0K
YoY Change	-28.99%		27.74%
Long-Term Investments
YoY Change
Other Assets	$117.0K	$1.520M	$135.0K
YoY Change	317.86%	1025.93%	-19.64%
Total Long-Term Assets	$7.917M	$8.181M	$9.160M
YoY Change	-8.78%	-10.69%	-6.03%
TOTAL ASSETS
Total Short-Term Assets	$8.313M	$10.38M	$13.24M
Total Long-Term Assets	$7.917M	$8.181M	$9.160M
Total Assets	$16.23M	$18.56M	$22.40M
YoY Change	-23.6%	-17.15%	-2.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.387M	$1.944M	$1.491M
YoY Change	2.66%	30.38%	58.28%
Accrued Expenses	$960.0K	$1.010M	$870.0K
YoY Change	10.34%	16.09%	-42.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.660M	$2.540M	$1.000M
YoY Change	109.45%	154.0%	-15.97%
Long-Term Debt Due	$3.604M	$3.673M	$3.900M
YoY Change	1160.14%	-5.82%	1323.36%
Total Short-Term Liabilities	$8.622M	$9.191M	$7.280M
YoY Change	126.66%	26.25%	85.71%
LONG-TERM LIABILITIES
Long-Term Debt	$10.00K	$14.00K	$60.00K
YoY Change	-99.72%	-76.67%	-98.48%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$10.00K	$14.00K	$60.00K
YoY Change	-99.72%	-76.67%	-98.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.622M	$9.191M	$7.280M
Total Long-Term Liabilities	$10.00K	$14.00K	$60.00K
Total Liabilities	$8.632M	$9.205M	$7.410M
YoY Change	16.48%	24.22%	-5.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.20M	-$9.471M
YoY Change	197.8%
Common Stock	$26.37M	$26.40M
YoY Change	-0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.634M	$6.312M
YoY Change	-22.34%
Treasury Stock Shares	1.699M shares	1.909M shares	2.235K shares
Shareholders Equity	$7.369M	$9.261M	$15.00M
YoY Change
Total Liabilities & Shareholders Equity	$16.23M	$18.56M	$22.40M
YoY Change	-23.6%	-17.14%	-2.22%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$2.140M	-$1.958M	$584.0K
YoY Change	219.4%	-435.27%	-184.88%
Depreciation, Depletion And Amortization	$310.0K	$360.0K	$360.0K
YoY Change	-8.82%	0.0%	16.13%
Cash From Operating Activities	-$440.0K	$670.0K	$2.330M
YoY Change	-59.63%	-71.24%	454.76%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$20.00K	$90.00K
YoY Change	-100.0%	-77.78%	50.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$20.00K	-$90.00K
YoY Change	-100.0%	-77.78%	50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	160.0K	-380.0K	-860.0K
YoY Change	-36.0%	-55.81%	79.17%
NET CHANGE
Cash From Operating Activities	-440.0K	670.0K	2.330M
Cash From Investing Activities	0.000	-20.00K	-90.00K
Cash From Financing Activities	160.0K	-380.0K	-860.0K
Net Change In Cash	-280.0K	270.0K	1.380M
YoY Change	-76.47%	-80.43%	-1250.0%
FREE CASH FLOW
Cash From Operating Activities	-$440.0K	$670.0K	$2.330M
Capital Expenditures	$0.00	$20.00K	$90.00K
Free Cash Flow	-$440.0K	$650.0K	$2.240M
YoY Change	-69.44%	-70.98%	522.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Line Of Credit LineOfCredit	2539000	USD
CY2014Q4	us-gaap	Line Of Credit LineOfCredit	1269000	USD
CY2015Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	3673000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	286000	USD
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2183	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	9261000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	13738000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8659000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5704000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5173000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4931000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	3486000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	773000	USD
CY2014Q3	us-gaap	Selling Expense SellingExpense	807000	USD
CY2015Q3	us-gaap	Selling Expense SellingExpense	776000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1161000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1003000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	865000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	869000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	653000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1875000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	69000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	83000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	584000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1958000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	584000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-1958000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.09
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	23065000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	15729000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	14347000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12040000	USD
	us-gaap	Gross Profit GrossProfit	8718000	USD
	us-gaap	Gross Profit GrossProfit	3689000	USD
	us-gaap	Selling Expense SellingExpense	2500000	USD
	us-gaap	Selling Expense SellingExpense	2392000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3631000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3085000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2634000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2598000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-47000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4386000	USD
	us-gaap	Interest Expense InterestExpense	183000	USD
	us-gaap	Interest Expense InterestExpense	249000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	369000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1944000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1351000	USD
CY2015Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	553000	USD
CY2014Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	513000	USD
CY2015Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	260000	USD
CY2014Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	260000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	24000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	24000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	198000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	101000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9191000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3804000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3607000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	95000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	95000	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26390000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26435000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9471000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4096000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1354000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1354000	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	6312000	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	7255000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-230000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4635000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-230000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4635000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.72
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6555000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6226000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6407000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6220000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6555000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6320000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6407000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6220000	shares
	us-gaap	Depreciation Depreciation	339000	USD
	us-gaap	Depreciation Depreciation	367000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	735000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	634000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	186000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	158000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	107000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1026000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-560000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-239000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-958000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-845000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	244000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-367000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-24000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	102000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	272000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	730000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2707000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-356000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	508000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	188000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-877000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-636000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	204000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	206000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-275000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1270000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-467000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1064000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1363000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	72000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1430000	USD
	us-gaap	Interest Paid InterestPaid	190000	USD
	us-gaap	Interest Paid InterestPaid	221000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	448000	USD
CY2015Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	4791000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5151000	USD
CY2015Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2233000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3045000	USD
	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	1	pure
CY2015Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5391000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5487000	USD
CY2015Q3	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	3401000	USD
CY2014Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	2798000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	BLONDER TONGUE LABORATORIES INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001000683
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	BDR
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6554736	shares
CY2015Q3	us-gaap	Assets Assets	18561000	USD
CY2014Q4	us-gaap	Assets Assets	21244000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18561000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21244000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	2648000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	2833000	USD
	us-gaap	Operating Expenses OperatingExpenses	8075000	USD
	us-gaap	Operating Expenses OperatingExpenses	8765000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12000	USD
CY2014Q4	us-gaap	Inventory Gross InventoryGross	13683000	USD
CY2014Q4	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	4426000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	191000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	171000	USD
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8464000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8464000	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6555000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6263000	shares
CY2015Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1909000	shares
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2202000	shares
CY2014	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.66	pure
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1015	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1799	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1443	shares
CY2015Q3	us-gaap	Inventory Write Down InventoryWriteDown	1008000	USD

Files In Submission

Name	View Source	Status
0001144204-15-065561-index-headers.html	Edgar Link	pending
0001144204-15-065561-index.html	Edgar Link	pending
0001144204-15-065561.txt	Edgar Link	pending
0001144204-15-065561-xbrl.zip	Edgar Link	pending
bdr-20150930.xml	Edgar Link	completed
bdr-20150930.xsd	Edgar Link	pending
bdr-20150930_cal.xml	Edgar Link	unprocessable
bdr-20150930_def.xml	Edgar Link	unprocessable
bdr-20150930_lab.xml	Edgar Link	unprocessable
bdr-20150930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v424280_10q.htm	Edgar Link	pending
v424280_ex10-3.htm	Edgar Link	pending
v424280_ex10-4.htm	Edgar Link	pending
v424280_ex10-5.htm	Edgar Link	pending
v424280_ex31-1.htm	Edgar Link	pending
v424280_ex31-2.htm	Edgar Link	pending
v424280_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

2015 Q4 Form 10-Q Financial Statement

#000114420415065561 Filed on November 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL BLONDER TONGUE LABORATORIES INC Stock $bdrl

2015 Q4 Form 10-Q Financial Statement

#000114420415065561 Filed on November 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl